Q1 2024 Holdings
Filed 2024-04-24 | 228 holdings | $165.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Pfizer Inc(PFE) | COM | 717081103 | $4.9M | 175,000 | 2.9% |
| Rithm Capital Corp(RITM) | COM NEW | 64828T201 | $4.7M | 420,966 | 2.8% |
| Harmony Biosciences Hldgs in(HRMY) | COM | 413197104 | $4.1M | 122,000 | 2.5% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $3.7M | 16,000 | 2.2% |
| Pacira Biosciences Inc(PCRX) | COM | 695127100 | $3.4M | 117,500 | 2.1% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $3.4M | 675,000 | 2.1% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $3.4M | 105,000 | 2.0% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $3.1M | 8,000 | 1.9% |
| Two Harbors Inventment Corpo | NOTE 6.250% 1/1 | 90187BAB7 | $3.0M | 3,205,000 | 1.8% |
| Inari MED Inc(NARIUSD) | COM | 45332Y109 | $3.0M | 63,000 | 1.8% |
| Docgo Inc(DCGO) | COM | 256086109 | $2.6M | 650,000 | 1.6% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $2.6M | 16,750 | 1.6% |
| Ellington Financial Inc(EFC) | COM | 28852N109 | $2.6M | 221,602 | 1.6% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $2.6M | 32,500 | 1.6% |
| Mgic Invt Corp WIS(MTG) | COM | 552848103 | $2.6M | 114,379 | 1.5% |
| Uniqure NV(QURE) | SHS | N90064101 | $2.4M | 460,000 | 1.4% |
| Coherus Biosciences Inc(CHRS) | COM | 19249H103 | $2.4M | 1,000,000 | 1.4% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $2.4M | 94,000 | 1.4% |
| Dynex Cap Inc(DX) | COM | 26817Q886 | $2.3M | 181,492 | 1.4% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $2.2M | 143,898 | 1.3% |
| Corcept Therapeutics Inc(CORT) | COM | 218352102 | $2.1M | 85,000 | 1.3% |
| Perspective Therapeutics Inc | COM | 46489V104 | $2.1M | 1,756,756 | 1.3% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $2.1M | 175,000 | 1.2% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $2.0M | 29,000 | 1.2% |
| Pennymac Corp | NOTE 5.500%11/0 | 70932AAD5 | $1.9M | 1,965,000 | 1.2% |
| MFA Finl Inc(MFA) | COM | 55272X607 | $1.9M | 167,725 | 1.2% |
| Redwood Trust Inc(RWT) | COM | 758075402 | $1.8M | 288,343 | 1.1% |
| Royalty Pharma PLC(RPRX) | SHS CLASS A | G7709Q104 | $1.8M | 60,000 | 1.1% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $1.8M | 42,500 | 1.1% |
| Medtronic PLC(MDT) | SHS | G5960L103 | $1.8M | 20,500 | 1.1% |
| Karyopharm Therapeutics Inc(KPTIEUR) | COM | 48576U106 | $1.7M | 1,125,000 | 1.0% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $1.6M | 38,500 | 1.0% |
| Invesco Exchange Traded FD T(RPV) | S&P500 PUR VAL | 46137V258 | $1.6M | 17,834 | 1.0% |
| Stereotaxis Inc(STXS) | COM NEW | 85916J409 | $1.6M | 600,000 | 0.9% |
| Ishares TR(IWD) | RUS 1000 VAL ETF | 464287598 | $1.6M | 8,671 | 0.9% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $1.5M | 130,000 | 0.9% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $1.5M | 122,500 | 0.9% |
| GSK PLC(GSK) | SPONSORED ADR | 37733W204 | $1.5M | 35,000 | 0.9% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $1.5M | 60,000 | 0.9% |
| Arrivent Biopharma Inc(AVBP) | COM | 04272N102 | $1.5M | 83,000 | 0.9% |
| Embecta Corp(EMBC) | COMMON STOCK | 29082K105 | $1.5M | 111,500 | 0.9% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $1.5M | 18,000 | 0.9% |
| New York MTG TR Inc(ADAM) | COM | 649604840 | $1.4M | 200,963 | 0.9% |
| Synopsys Inc(SNPS) | COM | 871607107 | $1.4M | 2,500 | 0.9% |
| Tourmaline BIO Inc(TRML) | COM | 89157D105 | $1.4M | 61,100 | 0.8% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $1.4M | 20,000 | 0.8% |
| Vyne Therapeutics Inc(VYNE) | COM | 92941V308 | $1.4M | 445,000 | 0.8% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $1.4M | 15,500 | 0.8% |
| Equity Lifestyle Pptys Inc(ELS) | COM | 29472R108 | $1.3M | 20,611 | 0.8% |
| Enact Hldgs Inc(ACT) | COM | 29249E109 | $1.3M | 42,367 | 0.8% |